Beam Therapeutics Inc (BEAM) poses a Brand-New Opportunity for Investors with beta value of 2.35
Beam Therapeutics Inc (NASDAQ: BEAM) established initial surge of 1.12% at $19.93, as the Stock market unbolted on Wednesday, before settling in for the price